Götzinger, Felix
Kunz, Michael
Lauder, Lucas
Böhm, Michael
Mahfoud, Felix
Article History
Received: 27 March 2022
Revised: 13 April 2022
Accepted: 16 April 2022
First Online: 13 May 2022
Change Date: 15 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41440-022-00975-4
<!--Emphasis Type='Bold' removed-->Compliance with ethical standards
:
: FG is supported by the German Heart Foundation/German Foundation for Heart Research. LL received speaker honoraria from Medtronic and ReCor Medical. MB is supported by Abbott, Amgen, Astra-Zeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Deutsche Forschungsgemeinschaft (DFG, SFB TRR219, S-01, M-03, M-05), Medtronic, Novartis, ReCor Medical, Servier and Vifor. FM is supported by Deutsche Gesellschaft für Kardiologie (DGK) and Deutsche Forschungsgemeinschaft (SFB TRR219) as well as by the German Heart Foundation/German Foundation for Heart Research. He has received scientific support and speaker honoraria from Bayer, Boehringer Ingelheim, Medtronic and ReCor Medical. The other authors do not have any conflicts of interest.